Collectively, these findings identify CXCL10 as a key chemokine upregulated upon PRMT5 deficiency, suggesting that PRMT5 may influence the recruitment of CD8+ T cells via the CXCL10 signaling pathway in cervical cancer. Here, PRMT5 is linked to cervical carcinoma.